To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RABEP1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
368 representative clones for gene RABEP1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA205888 brain .a -11 to 548 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA238893 brain .a -11 to 577 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
DA209484 brain .a -10 to 550 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA245388 brain .a -10 to 584 2 to 596   capped   595/595
(100 %)
2 diff
(99.7 %id)
DA405474 thalamus .a -10 to 535 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA580132   .a -10 to 511 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
DA773401 brain .a -10 to 555 2 to 568   capped   567/567
(100 %)
3 diff
(99.5 %id)
BP312862 mammary gland .a -10 to 569 1 to 580       580/583
(99 %)
3 diff
(99.5 %id)
DA445866 tongue, tumor tissue .a -9 to 547 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DA491363 brain .a -9 to 564 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA527067 brain .a -9 to 561 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA606103   .a -9 to 523 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
DA764797 tongue .a -9 to 571 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DA771445 brain .a -9 to 555 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA778427 brain .a -9 to 559 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
BI559885 testis .a 1 to 65 7 to 71       71/71
(100 %)
5 diff
(93.0 %id)
CN285993 embryonic stem cells, cell lines H1, H7, andH9 .a 1 to 506 12 to 517       511/517
(98 %)
7 diff
(98.7 %id)
DA613321   .a 1 to 573 6 to 578   tiling clone, capped   577/577
(100 %)
0 diff
(100 %id)
DA046433 bladder .a 1 to 533 5 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
DA461777 tongue, tumor tissue .a 1 to 333 5 to 337   capped   336/336
(100 %)
3 diff
(99.2 %id)
DB461642 testis .a 1 to 473 3 to 475       475/475
(100 %)
2 diff
(99.6 %id)
TI_44348365   .a 1 to 734 125 to 868       743/938
(79 %)
31 diff
(96.7 %id)
DA149794 amygdala .a 1 to 236 2 to 237   capped   236/251
(94 %)
2 diff
(99.3 %id)
DA635440 Kidney .a 1 to 510 2 to 511   capped   510/510
(100 %)
0 diff
(100 %id)
AL041200 testis .a 4 to 424 1 to 422       422/422
(100 %)
3 diff
(99.3 %id)
BG168445 hypernephroma, cell line, Kidney .a 6 to 186 1 to 181       181/181
(100 %)
1 diff
(99.5 %id)
CA975909 sciatic nerve .a 8 to 738 1 to 733       733/931
(78 %)
21 diff
(97.8 %id)
BG897810 cartilage .a 10 to 565 56 to 610       555/610
(90 %)
9 diff
(98.6 %id)
CN285994 embryonic stem cells, cell lines H1, H7, andH9 .a 10 to 609 1 to 600       600/600
(100 %)
2 diff
(99.7 %id)
DN989961 brain, whole brain .a 12 to 675 1 to 664       664/664
(100 %)
6 diff
(99.1 %id)
CN285992 embryonic stem cells, cell lines H1, H7, andH9 .a 14 to 732 1 to 719       719/719
(100 %)
0 diff
(100 %id)
X91141   .a 14 to 2979 1 to 2965 S149Y tiling clone,   2965/2965
(100 %)
6 diff
(99.8 %id)
BQ433172 embryonal carcinoma, cell line, testis .a 15 to 860 1 to 849       849/882
(96 %)
12 diff
(98.7 %id)
BG249114 hypernephroma, cell line, Kidney .a 16 to 186 1 to 170   available from MGC,   170/170
(100 %)
1 diff
(99.5 %id)
BG612294 adenocarcinoma, Prostate .a 16 to 672 1 to 658       658/661
(99 %)
10 diff
(98.5 %id)
BI117471 lung, small cell carcinoma .a 27 to 731 1 to 706   available from MGC,   706/916
(77 %)
13 diff
(98.6 %id)
BQ213924 embryonal carcinoma, cell line, testis .a 28 to 731 1 to 709       709/926
(76 %)
11 diff
(98.9 %id)
BQ439490 large cell carcinoma, lung .a 56 to 729 1 to 673   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 673/954
(70 %)
16 diff
(98.4 %id)
CR984527 T-Lymphocytes .a 72 to 803 1 to 732       732/732
(100 %)
3 diff
(99.6 %id)
AI341254 pooled germ cell tumors .a 191 to 711 521 to 1       521/521
(100 %)
1 diff
(99.9 %id)
AK314183 brain .a 237 to 2791 250 to 2804 M628I tiling clone,   2804/2804
(100 %)
7 diff
(99.8 %id)
DA104793 cerebellum .a 237 to 561 252 to 576   capped   575/575
(100 %)
4 diff
(99.4 %id)
DA187770 amygdala .a 237 to 523 259 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA223977 brain .a 237 to 539 252 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DA247820 brain .a 237 to 560 255 to 578   capped   577/577
(100 %)
5 diff
(99.2 %id)
DA297867 hippocampus .a 237 to 444 375 to 582   capped   465/581
(80 %)
6 diff
(99.0 %id)
DA448339 tongue, tumor tissue .a 237 to 553 257 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DT220453 brain .a 237 to 671 252 to 686       686/686
(100 %)
6 diff
(99.2 %id)
DA511431 brain .a 237 to 529 257 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
BP249121 Kidney .a 237 to 561 257 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DA641233 Liver .a 237 to 526 256 to 545   capped   544/544
(100 %)
3 diff
(99.5 %id)
DA743572   .a 237 to 527 257 to 547   capped   546/546
(100 %)
2 diff
(99.7 %id)
DA965002 stomach .a 237 to 501 251 to 515   capped   514/514
(100 %)
0 diff
(100 %id)
DB084803 testis .a 237 to 527 260 to 550   capped   542/542
(100 %)
3 diff
(99.5 %id)
DB084805 testis .a 237 to 527 258 to 548   capped   540/541
(99 %)
2 diff
(99.7 %id)
DB169027 kidney, tumor tissue .a 237 to 538 259 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
R29516   .a 250 to 463 1 to 213       213/215
(99 %)
11 diff
(94.9 %id)
DA182523 amygdala .a 274 to 855 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
BP234604 coronary artery .a 315 to 891 1 to 577       577/577
(100 %)
1 diff
(99.9 %id)
CR744611 uterus .a 316 to 587 1 to 272       272/272
(100 %)
0 diff
(100 %id)
BQ954309 sciatic nerve .a 337 to 1166 1 to 840   tiling clone,   840/907
(92 %)
23 diff
(97.5 %id)
CN285995 embryonic stem cells, DMSO-treated H9 cellline .a 358 to 1103 7 to 752       746/752
(99 %)
1 diff
(99.9 %id)
BC032435 Kidney, hypernephroma .b 1 to 2333 11 to 2343   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 2333/2339
(99 %)
3 diff
(99.9 %id)
DB222282 trachea .b 2290 to 2871 2 to 579   tiling clone, capped   578/578
(100 %)
7 diff
(98.8 %id)
BE144449 head_neck .b 2615 to 3033 1 to 411       411/411
(100 %)
11 diff
(97.4 %id)
BE144438 head_neck .b 2620 to 3033 9 to 418   tiling clone,   410/418
(98 %)
6 diff
(98.6 %id)
AF098638   .c 1 to 2490 1 to 2490 S149Y tiling clone,   2490/2490
(100 %)
2 diff
(100.0 %id)
BU958698 mixed (pool of 40 RNAs) .c 1690 to 2423 1 to 737       737/737
(100 %)
11 diff
(98.6 %id)
AW965007   .c 1906 to 2508 1 to 604   tiling clone,   604/604
(100 %)
6 diff
(99.1 %id)
AK297535 brain .d -10 to 2864 1 to 2875 I48V E224K Q762H tiling clone,   2875/2875
(100 %)
7 diff
(99.8 %id)
DA518694 brain .d -9 to 550 2 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
DB232309 trachea .d 39 to 602 2 to 565   tiling clone, capped   564/572
(98 %)
2 diff
(99.7 %id)
BU931542 ovary, teratocarcinoma, cell line .d 245 to 1110 1 to 872       872/872
(100 %)
9 diff
(99.0 %id)
TI_159693964   .d 246 to 888 60 to 702     Submitted on the opposite strand 643/1063
(60 %)
10 diff
(99.1 %id)
TI_159698314   .d 246 to 888 51 to 694     Submitted on the opposite strand 644/1064
(60 %)
11 diff
(99.0 %id)
CF786022 mixed .d 370 to 1137 8 to 765       758/791
(95 %)
20 diff
(97.5 %id)
DA698211   .d 377 to 948 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BQ213673 melanotic melanoma, skin .d 436 to 1293 1 to 871   tiling clone,   871/892
(97 %)
26 diff
(97.1 %id)
CA391195 eye, RPE/choroid .d 437 to 810 1 to 374       374/374
(100 %)
0 diff
(100 %id)
DA799768 brain .d 439 to 983 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
EC471959 Prostate .d 481 to 582 103 to 2       102/103
(99 %)
0 diff
(100 %id)
DN917096   .d 502 to 1079 578 to 1       578/578
(100 %)
7 diff
(98.8 %id)
W27092 eye, retina .d 645 to 1095 475 to 20       456/505
(90 %)
12 diff
(97.7 %id)
DT220609 brain .d 654 to 1279 1 to 626       626/626
(100 %)
1 diff
(99.9 %id)
DA208889 brain .d 700 to 1271 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
AW501546 lymph .d 709 to 1174 7 to 472       466/472
(98 %)
0 diff
(100 %id)
TI_154156535   .d 709 to 1297 79 to 664       586/624
(93 %)
17 diff
(97.3 %id)
CN285990 embryonic stem cells, cell lines H1, H7, andH9 .d 731 to 1455 1 to 725       725/725
(100 %)
0 diff
(100 %id)
DA414256 thalamus .d 738 to 1311 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BP268694 thyroid .d 741 to 1323 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP269171 thyroid .d 741 to 1323 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA194334 amygdala .d 784 to 1363 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
DB240408 trachea .d 787 to 1362 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
BG757928 B-cells, primary B-cells from tonsils (cell line) .d 831 to 1443 1 to 613       613/614
(99 %)
2 diff
(99.7 %id)
DA805592 brain .d 832 to 1389 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DB213623 trachea .d 836 to 1382 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA233715 brain .d 848 to 1422 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB275971 uterus .d 909 to 1477 2 to 570   capped   569/571
(99 %)
2 diff
(99.7 %id)
BE798033 lung, small cell carcinoma .d 965 to 1843 40 to 921       882/1224
(72 %)
27 diff
(97.8 %id)
DA410530 thalamus .d 978 to 1461 2 to 485   capped   484/484
(100 %)
0 diff
(100 %id)
BE793994 lung, small cell carcinoma .d 984 to 1730 1 to 746       746/746
(100 %)
1 diff
(99.9 %id)
BE700072 nervous_normal .d 1006 to 1250 1 to 245       245/245
(100 %)
0 diff
(100 %id)
BM017918 astrocytoma grade IV, cell line, brain .d 1035 to 1745 10 to 723       712/977
(72 %)
22 diff
(97.8 %id)
TI_59388496   .d 1035 to 1745 110 to 823       712/976
(72 %)
20 diff
(98.0 %id)
CN285996 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 1066 to 1808 1 to 743   tiling clone,   743/743
(100 %)
0 diff
(100 %id)
BE378234 endometrium, adenocarcinoma cell line, uterus .d 1069 to 1694 1 to 626       626/626
(100 %)
0 diff
(100 %id)
BG577338 breast, mammary adenocarcinoma, cell line .d 1070 to 1800 1 to 739       737/739
(99 %)
14 diff
(98.2 %id)
BF793025 adrenal cortex carcinoma, cell line, adrenal gland .d 1072 to 1843 1 to 776       776/927
(83 %)
22 diff
(97.7 %id)
DB222090 trachea .d 1092 to 1667 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA247202 brain .d 1102 to 1701 2 to 601   capped   600/600
(100 %)
0 diff
(100 %id)
BP277783   .d 1102 to 1690 1 to 589       589/589
(100 %)
4 diff
(99.4 %id)
DA214992 brain .d 1103 to 1656 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA220828 brain .d 1103 to 1596 2 to 495   capped   494/494
(100 %)
0 diff
(100 %id)
DB237271 trachea .d 1104 to 1596 2 to 495   capped   494/494
(100 %)
4 diff
(99.2 %id)
BP356688 mammary gland .d 1105 to 1688 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA190069 amygdala .d 1106 to 1680 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BP357169 mammary gland .d 1106 to 1678 10 to 582       573/582
(98 %)
6 diff
(99.0 %id)
DA327884 hippocampus .d 1107 to 1669 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DB151471 thymus .d 1110 to 1669 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA407451 thalamus .d 1123 to 1590 2 to 470   capped   469/469
(100 %)
3 diff
(99.4 %id)
DB042979 testis .d 1155 to 1722 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA191979 amygdala .d 1156 to 1749 2 to 595   capped   594/596
(99 %)
0 diff
(100 %id)
DB141266 thymus .d 1156 to 1713 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA856291 placenta .d 1158 to 1745 2 to 587   capped   586/590
(99 %)
3 diff
(99.5 %id)
DA214721 brain .d 1162 to 1708 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA316560 hippocampus .d 1166 to 1718 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA224663 brain .d 1205 to 1875 2 to 672   capped   671/671
(100 %)
0 diff
(100 %id)
DA412947 thalamus .d 1231 to 1786 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
AU124154   .d 1248 to 1966 2 to 718   capped   717/721
(99 %)
9 diff
(98.8 %id)
DA229998 brain .d 1260 to 1796 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA232346 brain .d 1297 to 1864 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
AL118955 amygdala .d 1406 to 1921 1 to 516       516/516
(100 %)
0 diff
(100 %id)
DB142725 thymus .d 1425 to 1989 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA446194 tongue, tumor tissue .d 1471 to 2037 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DB237120 trachea .d 1477 to 2066 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
DA216207 brain .d 1488 to 1990 2 to 504   capped   503/503
(100 %)
1 diff
(99.9 %id)
DA100043 cerebellum .d 1522 to 2068 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BU902807 leiomyosarcoma, uterus .d 1535 to 2286 1 to 762       762/934
(81 %)
26 diff
(97.3 %id)
DA413239 thalamus .d 1553 to 2099 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA100492 cerebellum .d 1560 to 2129 2 to 571   capped   570/570
(100 %)
5 diff
(99.2 %id)
DA795736 brain .d 1564 to 2028 2 to 466   capped   465/465
(100 %)
0 diff
(100 %id)
BP357058 mammary gland .d 1575 to 2171 1 to 598       598/598
(100 %)
7 diff
(98.9 %id)
DB216260 trachea .d 1606 to 2127 2 to 523   capped   522/522
(100 %)
1 diff
(99.9 %id)
BU177244 melanotic melanoma, skin .d 1616 to 2335 12 to 731   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 720/732
(98 %)
11 diff
(98.5 %id)
DA233649 brain .d 1651 to 2248 2 to 598   capped   597/599
(99 %)
3 diff
(99.5 %id)
AW504043 lymph .d 1673 to 2166 4 to 498       495/498
(99 %)
7 diff
(98.6 %id)
DR155980 human embryonic stem cells differentiated toan early endodermal cell type .d 1694 to 2444 762 to 13     Submitted on the opposite strand 750/762
(98 %)
1 diff
(99.9 %id)
BG424751 Kidney, renal cell adenocarcinoma .d 1727 to 2442 1 to 717       717/1155
(62 %)
21 diff
(98.2 %id)
BE387387 melanotic melanoma, skin .d 1744 to 2342 32 to 630       599/630
(95 %)
9 diff
(98.6 %id)
DA348708 substantia nigra .d 1796 to 2344 2 to 551   capped   550/556
(98 %)
3 diff
(99.5 %id)
DA317123 hippocampus .d 1797 to 2354 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DB079916 testis .d 1848 to 2415 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BG613671 embryonal carcinoma, testis .d 1885 to 2622 1 to 742       742/742
(100 %)
9 diff
(98.8 %id)
DA818363   .d 1902 to 2452 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA782681 brain .d 1915 to 2493 2 to 580   capped   579/580
(99 %)
3 diff
(99.5 %id)
AW373652 breast .d 1923 to 2530 9 to 615       607/615
(98 %)
10 diff
(98.4 %id)
AW373690 breast .d 1933 to 2573 19 to 658       640/658
(97 %)
14 diff
(97.9 %id)
AA313510 colon .d 1949 to 2323 1 to 375       375/375
(100 %)
0 diff
(100 %id)
DB141516 thymus .d 1958 to 2413 2 to 457   capped   456/456
(100 %)
2 diff
(99.6 %id)
AW502002 lymph .d 1989 to 2400 1 to 412       412/412
(100 %)
4 diff
(99.1 %id)
BG757640 B-cells, primary B-cells from tonsils (cell line) .d 2039 to 2757 1 to 721       721/976
(73 %)
19 diff
(98.1 %id)
BE070455 breast .d 2063 to 2505 1 to 441       441/441
(100 %)
1 diff
(99.8 %id)
BE070390 breast .d 2087 to 2516 5 to 434       430/434
(99 %)
0 diff
(100 %id)
BX103338 uterus .d 2099 to 2793 1 to 696       696/696
(100 %)
1 diff
(99.9 %id)
BM804460 lymph, lymphoma, cell line .d 2138 to 2931 1 to 799       799/1093
(73 %)
17 diff
(98.5 %id)
DA196152 amygdala .d 2166 to 2730 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
DB155202 thymus .d 2175 to 2777 2 to 604   capped   603/603
(100 %)
5 diff
(99.2 %id)
AL597808   .d 2182 to 2820 1 to 639       639/639
(100 %)
5 diff
(99.3 %id)
DA506595 brain .d 2193 to 2763 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
DA805811 brain .d 2224 to 2758 2 to 536   capped   535/535
(100 %)
3 diff
(99.5 %id)
BP326449 prostata .d 2233 to 2812 1 to 580       580/580
(100 %)
4 diff
(99.4 %id)
BP274378 Kidney .d 2236 to 2815 1 to 580       580/580
(100 %)
3 diff
(99.5 %id)
BE883918 leiomyosarcoma, uterus .d 2265 to 3031 1 to 761       761/771
(98 %)
17 diff
(97.8 %id)
DB164994 thymus .d 2288 to 2879 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
DA777864 brain .d 2297 to 2864 2 to 570   capped   569/569
(100 %)
5 diff
(99.2 %id)
FN131926 breast carcinoma .d 2298 to 2397 100 to 1     Submitted on the opposite strand 100/100
(100 %)
4 diff
(96.0 %id)
BM012122 brain, neuroblastoma, cell line .d 2338 to 3030 1 to 693   tiling clone,   693/711
(97 %)
12 diff
(98.4 %id)
AL708278 human skeletal muscle .d 2339 to 2937 1 to 599       599/599
(100 %)
6 diff
(99.0 %id)
TI_59381322   .d 2339 to 3030 103 to 794       692/710
(97 %)
11 diff
(98.5 %id)
FN113049 breast carcinoma .d 2347 to 2449 103 to 1     Submitted on the opposite strand 103/103
(100 %)
0 diff
(100 %id)
AL120839 melanoma (MeWo cell line) .d 2406 to 2982 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
BP345776 synovial membrane .d 2406 to 2984 1 to 579       579/579
(100 %)
4 diff
(99.4 %id)
DA706636   .d 2445 to 2981 2 to 538   tiling clone, capped   537/537
(100 %)
0 diff
(100 %id)
BM823100 stomach .d 2542 to 2911 1 to 370       370/370
(100 %)
3 diff
(99.2 %id)
FN054204 breast carcinoma .d 2574 to 2670 1 to 97       97/97
(100 %)
0 diff
(100 %id)
AK310932 trachea .e 1 to 2767 2 to 2768 exact tiling clone,   2768/2770
(99 %)
3 diff
(99.9 %id)
BM722352 eye, fetal eye .f 1 to 729 1 to 729   tiling clone, Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 729/729
(100 %)
0 diff
(100 %id)
W39555 parathyroid gland, parathyroid tumor .f 37 to 409 1 to 374       372/386
(96 %)
3 diff
(99.3 %id)
BM712378 eye, lens .f 685 to 1134 1 to 450   tiling clone, Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 450/450
(100 %)
2 diff
(99.6 %id)
F06378 brain, total brain .f 1030 to 1390 1 to 361   tiling clone,   361/361
(100 %)
3 diff
(99.2 %id)
Z39287 brain, total brain .f 2290 to 2623 334 to 1   tiling clone,   334/334
(100 %)
2 diff
(99.5 %id)
BU738282 eye, lens .f 3137 to 3696 577 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 559/559
(100 %)
5 diff
(99.2 %id)
W15394 parathyroid gland, parathyroid tumor .f 3286 to 3656 370 to 1       370/370
(100 %)
5 diff
(98.7 %id)
BU740187 eye, fetal eye .f 3305 to 3696 409 to 19   AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 391/391
(100 %)
5 diff
(98.8 %id)
BC018742 Lung, small cell carcinoma .g 1 to 905 1 to 905 exact tiling clone, available from MGC, AAA   905/905
(100 %)
0 diff
(100 %id)
CA310624 Human Lung Epithelial cells, lung .g 301 to 905 623 to 19   AAA   605/610
(99 %)
1 diff
(99.9 %id)
BI666786 brain, hypothalamus .h 1 to 805 7 to 806 exact tiling clone,   801/833
(96 %)
15 diff
(98.2 %id)
TI_44342979   .h 1 to 805 130 to 929 exact     801/1021
(78 %)
15 diff
(98.6 %id)
AI376112 uterus .h 325 to 806 482 to 2   tiling clone,   481/482
(99 %)
1 diff
(99.8 %id)
DB527065 testis .h 343 to 803 1 to 462     Submitted on the opposite strand 462/462
(100 %)
1 diff
(99.8 %id)
DB562974 hypothalamus .h 388 to 805 1 to 418     Submitted on the opposite strand 418/419
(99 %)
1 diff
(99.8 %id)
AW302815 invasive adenocarcinoma, lung .h 522 to 801 21 to 299     Submitted on the opposite strand 279/301
(92 %)
7 diff
(97.7 %id)
DA702863   .i 237 to 531 257 to 552 R105E A106S F108I K109* tiling clone, capped   551/551
(100 %)
2 diff
(99.7 %id)
AL042125 testis .j 1 to 533 1 to 535 exact tiling clone,   535/535
(100 %)
9 diff
(98.4 %id)
BG190348   .k-u 1 to 583 14 to 591   AAA   585/591
(98 %)
6 diff
(99.0 %id)
BG186203   .k-u 1 to 575 13 to 589   AAA   583/589
(98 %)
6 diff
(99.0 %id)
BG186202   .k-u 1 to 575 5 to 578   AAA   578/578
(100 %)
9 diff
(98.5 %id)
BG198422   .k-u 1 to 577 5 to 582   tiling clone,   582/582
(100 %)
8 diff
(98.7 %id)
BG191314   .k-u 1 to 577 4 to 581   AAA   581/581
(100 %)
14 diff
(97.6 %id)
BG207265   .k-u 1 to 575 4 to 580   tiling clone, AAA   580/580
(100 %)
9 diff
(98.5 %id)
BG186201   .k-u 1 to 575 11 to 585   tiling clone, AAA   577/585
(98 %)
6 diff
(99.0 %id)
BG209421   .k-u 1 to 574 11 to 589   AAA   580/589
(98 %)
6 diff
(99.0 %id)
BG183981   .k-u 7 to 575 21 to 593   AAA   573/593
(96 %)
6 diff
(99.0 %id)
BG204612   .k-u 7 to 575 17 to 590   AAA   574/590
(97 %)
6 diff
(99.0 %id)
BG214125   .k-u 7 to 584 20 to 600   AAA   581/600
(96 %)
6 diff
(99.0 %id)
BG201393   .k-u 8 to 575 12 to 580   AAA   569/580
(98 %)
6 diff
(99.0 %id)
BG220832   .k-u 8 to 568 10 to 572       563/846
(66 %)
33 diff
(96.1 %id)
BG209422   .k-u 13 to 580 58 to 627       570/992
(57 %)
6 diff
(99.4 %id)
BG200521   .k-u 18 to 577 17 to 570   AAA   554/571
(97 %)
7 diff
(98.8 %id)
BG198971   .k-u 28 to 575 42 to 590   AAA   549/590
(93 %)
6 diff
(99.0 %id)
BG197391   .k-u 29 to 551 43 to 568       526/863
(60 %)
25 diff
(97.2 %id)
BG205153   .k-u 31 to 294 1 to 263   tiling clone,   263/272
(96 %)
9 diff
(96.7 %id)
BG203118   .k-u 37 to 315 45 to 324       280/324
(86 %)
6 diff
(98.2 %id)
BG202571   .k-u 52 to 178 1 to 128       128/128
(100 %)
3 diff
(97.7 %id)
AI183392 placenta .k-u 222 to 578 357 to 1       357/357
(100 %)
1 diff
(99.8 %id)
BG033386 breast, mammary adenocarcinoma, cell line .k-u 319 to 1090 10 to 776 V2G tiling clone,   767/962
(79 %)
15 diff
(98.5 %id)
AI375588   .k-u 657 to 1136 481 to 2   tiling clone,   480/481
(99 %)
0 diff
(100 %id)
DA144226 amygdala .k-u 794 to 1331 2 to 539   tiling clone, capped   538/538
(100 %)
2 diff
(99.7 %id)
CV366506 testis_normal .k-u 937 to 1402 471 to 11   tiling clone, Submitted on the opposite strand 461/471
(97 %)
21 diff
(95.6 %id)
BX645543   .k-u 1266 to 1803 1 to 538   tiling clone,   538/539
(99 %)
7 diff
(98.8 %id)
BF129140 B-cells, primary B-cells from tonsils (cell line) .k-u 1450 to 1781 1 to 332   tiling clone,   332/332
(100 %)
0 diff
(100 %id)
R65711 placenta .k-u 1798 to 2167 1 to 379   tiling clone,   379/411
(92 %)
20 diff
(95.2 %id)
BM310079 insulinoma, Pancreas .k-u 2203 to 2623 8 to 428   tiling clone,   421/428
(98 %)
8 diff
(98.2 %id)
BM310345 insulinoma, Pancreas .k-u 2203 to 2621 435 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 419/425
(98 %)
0 diff
(100 %id)
CK905292 insulinoma, Pancreas .k-u 2203 to 2634 432 to 1       432/438
(98 %)
4 diff
(99.1 %id)
BQ023192 placenta .k-u 2219 to 2621 421 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 403/403
(100 %)
1 diff
(99.8 %id)
R65712 placenta .k-u 2227 to 2621 409 to 1       409/415
(98 %)
20 diff
(95.2 %id)
BI497324 cochlea, ear .k-u 2293 to 2621 1 to 329   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 329/329
(100 %)
4 diff
(98.8 %id)
FN131828 breast carcinoma .k-u 2522 to 2606 1 to 83       83/83
(100 %)
5 diff
(94.0 %id)
DB301363 amygdala .k-u 2548 to 3081 534 to 1   tiling clone,   534/534
(100 %)
4 diff
(99.3 %id)
BQ347113 nervous_tumor .k-u 3012 to 3171 160 to 1   tiling clone,   160/161
(99 %)
3 diff
(98.2 %id)
CV362273 nervous_tumor .k-u 3189 to 3458 293 to 26   tiling clone, Submitted on the opposite strand 268/293
(91 %)
0 diff
(100 %id)
AL157499 testis .l-u 1 to 2137 1 to 2137 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 2137/2137
(100 %)
1 diff
(100.0 %id)
DA730933   .l-u 70 to 807 168 to 906   capped   739/906
(81 %)
9 diff
(99.1 %id)
DA364672 subthalamic nucleus .l-u 91 to 648 2 to 559   capped   558/558
(100 %)
3 diff
(99.5 %id)
DA695167   .l-u 142 to 720 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
BQ695353 adipose .l-u 170 to 599 1 to 429       429/429
(100 %)
1 diff
(99.8 %id)
BU539206 adenocarcinoma, cell line, breast .l-u 186 to 1076 1 to 895       895/965
(92 %)
25 diff
(97.5 %id)
BU538207 adenocarcinoma, cell line, breast .l-u 188 to 1102 1 to 914       914/935
(97 %)
17 diff
(98.2 %id)
BU856917 adenocarcinoma, cell line, breast .l-u 188 to 942 1 to 759       759/883
(85 %)
8 diff
(99.1 %id)
BU957182 adenocarcinoma, cell line, breast .l-u 188 to 1087 1 to 900       900/900
(100 %)
6 diff
(99.4 %id)
DB033626 testis .l-u 202 to 790 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
DA979979 synovial membrane tissue from rheumatioidarthritis .l-u 218 to 780 2 to 563   capped   562/562
(100 %)
4 diff
(99.3 %id)
BG034497 breast, mammary adenocarcinoma, cell line .l-u 226 to 930 1 to 706       706/708
(99 %)
8 diff
(98.9 %id)
N54095 multiple sclerosis lesions .l-u 253 to 369 1 to 117       117/118
(99 %)
1 diff
(99.2 %id)
BG829157 muscle, rhabdomyosarcoma .l-u 285 to 921 1 to 636       636/636
(100 %)
5 diff
(99.3 %id)
BU169594 embryonal carcinoma, cell line, testis .l-u 352 to 1097 1 to 746       746/960
(77 %)
14 diff
(98.6 %id)
DB108343 thymus .l-u 383 to 958 2 to 578   capped   577/578
(99 %)
4 diff
(99.4 %id)
Z43595 brain, total brain .l-u 391 to 733 1 to 344       344/344
(100 %)
2 diff
(99.5 %id)
BM719229 eye, fetal eye .l-u 456 to 1094 1 to 639     Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 639/642
(99 %)
5 diff
(99.3 %id)
BU928862 brain, glioblastoma .l-u 460 to 1362 1 to 905       905/906
(99 %)
30 diff
(96.7 %id)
DA078748 cerebellum .l-u 463 to 1029 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
BF794741 lymph, lymphoma, cell line .l-u 490 to 1203 1 to 718       718/718
(100 %)
12 diff
(98.4 %id)
BM987608 mixed .l-u 529 to 1062 552 to 19   AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 534/534
(100 %)
1 diff
(99.9 %id)
BM473417 duodenal adenocarcinoma, cell line, small intestine .l-u 553 to 1483 10 to 959       950/1115
(85 %)
41 diff
(96.4 %id)
FN046892 breast carcinoma .l-u 596 to 695 1 to 100       100/100
(100 %)
0 diff
(100 %id)
AI767163 2 pooled tumors (clear cell type), Kidney .l-u 619 to 1063 447 to 3       445/447
(99 %)
0 diff
(100 %id)
BF449034 Prostate .l-u 619 to 1063 445 to 1       445/445
(100 %)
2 diff
(99.6 %id)
N51825 multiple sclerosis lesions .l-u 622 to 1065 447 to 1       447/447
(100 %)
4 diff
(99.2 %id)
AI631208 pooled germ cell tumors .l-u 633 to 1083 451 to 1       451/451
(100 %)
3 diff
(99.4 %id)
BM739541 stomach .l-u 640 to 1279 1 to 635       635/635
(100 %)
8 diff
(98.8 %id)
BM747648 stomach .l-u 640 to 1164 1 to 520       520/520
(100 %)
5 diff
(99.1 %id)
AA399073   .l-u 668 to 1246 16 to 594     Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 579/594
(97 %)
6 diff
(99.0 %id)
AI675544 Prostate .l-u 719 to 1055 353 to 17   AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 337/337
(100 %)
2 diff
(99.5 %id)
AI500479 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .l-u 740 to 1063 324 to 1       324/324
(100 %)
1 diff
(99.7 %id)
BM719033 eye, fetal eye .l-u 775 to 1443 1 to 669       669/669
(100 %)
1 diff
(99.9 %id)
AA873800 2 pooled tumors (clear cell type), Kidney .l-u 780 to 1004 225 to 1   tiling clone,   225/225
(100 %)
0 diff
(100 %id)
CV571031 cornea, eye .l-u 794 to 1407 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BQ673389 epidermoid carcinoma, cell line, salivary gland .l-u 938 to 1814 1 to 876 exact     876/876
(100 %)
15 diff
(98.3 %id)
BF575228 muscle (skeletal) .l-u 1023 to 1794 1 to 765 Q34K T35*     765/793
(96 %)
43 diff
(94.6 %id)
BM698987 eye, fetal eyes .l-u 1101 to 1615 1 to 515 exact fully sequenced, Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 515/515
(100 %)
2 diff
(99.7 %id)
BG109345 Bone, osteosarcoma, cell line .l-u 1138 to 1934 1 to 793 exact     793/918
(86 %)
18 diff
(98.1 %id)
CR624657 Placenta Cot 25-normalized .l-u 1145 to 2133 1 to 989 exact     989/989
(100 %)
0 diff
(100 %id)
AL550846 placenta, Placenta Cot 25-normalized .l-u 1145 to 2127 1 to 982 exact fully sequenced,   982/982
(100 %)
9 diff
(99.1 %id)
BI088265 cervix .l-u 1169 to 1942 1 to 767 C41V L42*     767/769
(99 %)
11 diff
(98.6 %id)
BE787793 large cell carcinoma, lung .l-u 1190 to 1905 1 to 710 C41V L42*     710/931
(76 %)
23 diff
(97.6 %id)
CB160655 Liver .l-u 1205 to 1776 1 to 572 exact     572/572
(100 %)
0 diff
(100 %id)
BQ720690 sympathetic trunk .l-u 1223 to 2075 1 to 856 exact     856/868
(98 %)
21 diff
(97.6 %id)
TI_149310673   .l-u 1291 to 2135 918 to 88 V2* AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 831/940
(88 %)
16 diff
(98.3 %id)
BU860389 adenocarcinoma, cell line, breast .l-u 1294 to 2135 1 to 848 exact AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 848/848
(100 %)
15 diff
(98.3 %id)
TI_149301758   .l-u 1361 to 2135 849 to 83 V2L L3V G4I K6H I7H ... AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 767/953
(80 %)
9 diff
(99.1 %id)
BM980069 lung, Primary Lung Cystic Fibrosis EpithelialCells .l-u 1365 to 2135 781 to 19 V2L L3V G4I K6H I7H ... AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 763/763
(100 %)
8 diff
(99.0 %id)
TI_154134329   .l-u 1376 to 2131 846 to 91 V2L G4V V16S A20Q T35S ... AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 756/756
(100 %)
9 diff
(98.9 %id)
BU688949 lung .l-u 1378 to 2135 771 to 19 V2C L3W G4* AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 753/753
(100 %)
6 diff
(99.3 %id)
BM683177 eye, fetal eye .l-u 1380 to 2135 767 to 19 G4V N5* AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 749/749
(100 %)
14 diff
(98.2 %id)
AL050211 uterus .l-u 1403 to 2135 1 to 733   available from DKFZ, AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 733/733
(100 %)
0 diff
(100 %id)
CK005342 brain/CNS, Human Brain - Frontal Cortex .l-u 1410 to 2069 1 to 655       655/657
(99 %)
13 diff
(98.1 %id)
BQ007157 Chondrosarcoma, Left Pelvis .l-u 1424 to 2135 725 to 15   AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 711/712
(99 %)
3 diff
(99.6 %id)
BM993807 Bone, Subchondral Bone .l-u 1424 to 2135 727 to 19   AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 709/710
(99 %)
9 diff
(98.8 %id)
CN479339 Bone, Subchondral Bone .l-u 1424 to 2135 727 to 19   AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 709/710
(99 %)
9 diff
(98.8 %id)
CA313505 Human Lung Epithelial cells, lung .l-u 1432 to 2135 721 to 19   AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 703/703
(100 %)
5 diff
(99.3 %id)
AA041239 heart .l-u 1466 to 1753 1 to 292   fully sequenced,   292/292
(100 %)
2 diff
(99.4 %id)
BQ019698 Chondrosarcoma, Left Pubic Bone .l-u 1470 to 2135 683 to 19   AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 665/666
(99 %)
8 diff
(98.8 %id)
BQ009339 Chondrosarcoma, Left Pubic Bone .l-u 1472 to 2131 677 to 19   AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 659/659
(100 %)
6 diff
(99.1 %id)
AA290870 germinal center B cell .l-u 1485 to 1851 1 to 366   fully sequenced, Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 366/366
(100 %)
3 diff
(99.2 %id)
BE765484 nervous_tumor .l-u 1561 to 1924 1 to 364       364/364
(100 %)
0 diff
(100 %id)
DB362945   .l-u 1578 to 2135 562 to 1       562/563
(99 %)
10 diff
(98.3 %id)
BU737421 eye, fetal eyes .l-u 1585 to 2135 567 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 549/549
(100 %)
6 diff
(99.0 %id)
Z28596 leg muscle, skeletal muscle .l-u 1593 to 1849 1 to 257       257/257
(100 %)
1 diff
(99.7 %id)
AL550977 placenta, Placenta Cot 25-normalized .l-u 1618 to 2103 484 to 1   fully sequenced,   484/484
(100 %)
2 diff
(99.6 %id)
AI436191 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l-u 1628 to 2136 511 to 3       509/511
(99 %)
0 diff
(100 %id)
AW089851 ovary, tumor, 5 pooled (see description) .l-u 1643 to 2135 493 to 1       493/493
(100 %)
4 diff
(99.2 %id)
AI023887 liver and spleen .l-u 1657 to 2131 476 to 1       476/476
(100 %)
2 diff
(99.6 %id)
AI090024 uterus .l-u 1662 to 2136 477 to 3       475/477
(99 %)
0 diff
(100 %id)
CR740128 pooled .l-u 1664 to 1982 1 to 318       318/318
(100 %)
3 diff
(99.1 %id)
BF002797 Prostate .l-u 1683 to 2132 450 to 1       450/450
(100 %)
1 diff
(99.8 %id)
BM856941 stomach .l-u 1688 to 2102 1 to 415       415/415
(100 %)
1 diff
(99.8 %id)
AI078176 liver and spleen .l-u 1693 to 2135 443 to 1       443/443
(100 %)
1 diff
(99.8 %id)
AA683232 schizophrenic brain S-11 frontal lobe .l-u 1704 to 2134 431 to 1       431/431
(100 %)
1 diff
(99.8 %id)
AA706411   .l-u 1711 to 2136 427 to 2       426/427
(99 %)
0 diff
(100 %id)
BF110940 carcinoid, lung .l-u 1713 to 2135 442 to 19   AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 424/424
(100 %)
2 diff
(99.6 %id)
AA040801 heart .l-u 1723 to 2136 415 to 1   fully sequenced,   415/415
(100 %)
0 diff
(100 %id)
AA693619 liver and spleen .l-u 1731 to 2131 402 to 1       402/402
(100 %)
2 diff
(99.6 %id)
AI367258 Kidney .l-u 1746 to 2135 390 to 1       390/390
(100 %)
0 diff
(100 %id)
AI955173 brain, four pooled pituitary adenomas .l-u 1758 to 2135 378 to 1       378/378
(100 %)
0 diff
(100 %id)
TI_151759422   .l-u 1767 to 2658 970 to 94   tiling clone, AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 877/935
(93 %)
22 diff
(97.7 %id)
W58520 heart .l-u 1792 to 2135 1 to 346   AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 346/346
(100 %)
2 diff
(99.5 %id)
AI826582 lymph node, lymphoma, follicular mixed small and largecell .l-u 1804 to 2135 350 to 19   AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 332/332
(100 %)
2 diff
(99.4 %id)
AI669191 Prostate .l-u 1807 to 2135 329 to 1       329/329
(100 %)
2 diff
(99.4 %id)
Z39660 brain, total brain .l-u 1814 to 2137 324 to 1       324/324
(100 %)
0 diff
(100 %id)
AA283713 germinal center B cell .l-u 1821 to 2135 326 to 13   fully sequenced, AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 314/314
(100 %)
2 diff
(99.4 %id)
AI910510 pooled .l-u 1825 to 2136 313 to 1       313/313
(100 %)
3 diff
(99.1 %id)
AA412174   .l-u 1882 to 2135 287 to 34   AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 254/254
(100 %)
0 diff
(100 %id)
AI301633 carcinoid, lung .l-u 1889 to 2136 248 to 1       248/248
(100 %)
0 diff
(100 %id)
DB154056 thymus .m-u 1 to 596 2 to 589   tiling clone, capped   588/590
(99 %)
17 diff
(97.2 %id)
AA203657 liver and spleen .m-u 517 to 1104 1 to 587   tiling clone,   587/912
(64 %)
11 diff
(98.8 %id)
FN173625 breast carcinoma .m-u 623 to 687 1 to 64       64/64
(100 %)
3 diff
(95.4 %id)
DW450165 Liver .m-u 1022 to 1195 199 to 26 S28C tiling clone,   174/199
(87 %)
0 diff
(100 %id)
BQ445919 Knee, Osteoarthritic Cartilage .n 1 to 645 654 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 636/655
(97 %)
12 diff
(98.2 %id)
AA621533   .n 429 to 649 233 to 13   tiling clone, AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 221/221
(100 %)
2 diff
(99.1 %id)
N45966 melanocyte .n 463 to 708 1 to 248   tiling clone,   248/251
(98 %)
5 diff
(98.1 %id)
N44279 melanocyte .n 464 to 789 1 to 333   tiling clone, fully sequenced,   333/333
(100 %)
6 diff
(98.2 %id)
AA778438 heart .n 615 to 1169 555 to 1 exact     555/555
(100 %)
2 diff
(99.7 %id)
AI539483 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 701 to 1168 471 to 4 exact     468/471
(99 %)
0 diff
(100 %id)
N20980 melanocyte .n 707 to 1165 462 to 1 exact     462/466
(99 %)
9 diff
(98.1 %id)
AI290486 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 710 to 1180 474 to 7 M32V tiling clone,   468/475
(98 %)
0 diff
(100 %id)
BM725683 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .n 723 to 1177 1 to 455 exact tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 455/455
(100 %)
0 diff
(100 %id)
DB352487.
matches multiple genes
uterus .n 739 to 1163 427 to 1 L10A L11P V12G V13G S14V ...   also hits gene ratoyu 427/429
(99 %)
4 diff
(99.1 %id)
N36403 melanocyte .n 759 to 1165 419 to 1   fully sequenced,   419/419
(100 %)
8 diff
(98.1 %id)
BF108508 carcinoid, lung .n 771 to 1165 399 to 5 M32V     395/399
(98 %)
0 diff
(100 %id)
BE670684 carcinoid, lung .n 788 to 1165 382 to 5 M32V     378/382
(98 %)
0 diff
(100 %id)
AI039516   .n 794 to 1180 391 to 5 M32V     387/391
(98 %)
0 diff
(100 %id)
AI279300 carcinoid, lung .n 820 to 1172 353 to 1 exact     353/353
(100 %)
0 diff
(100 %id)
AA831650 germinal center B cell .n 845 to 1172 346 to 19 exact AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 328/428
(76 %)
3 diff
(99.3 %id)
N36802 melanocyte .n 923 to 1165 243 to 1 A20X     243/254
(95 %)
0 diff
(100 %id)
BM678290 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .n 935 to 1177 261 to 19 exact fully sequenced, AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 243/243
(100 %)
0 diff
(100 %id)
W01037 liver and spleen .o-u 1 to 321 1 to 323   tiling clone, to resequence,   323/326
(99 %)
6 diff
(98.2 %id)
BG943021 blood .o-u 423 to 894 1 to 472   tiling clone,   472/472
(100 %)
3 diff
(99.4 %id)
AI806781 pooled .o-u 553 to 1124 572 to 1 exact     572/572
(100 %)
2 diff
(99.7 %id)
AW904430 nervous_normal .o-u 609 to 908 300 to 1       300/300
(100 %)
2 diff
(99.4 %id)
BX091215 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .o-u 666 to 1118 468 to 15 exact AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 454/454
(100 %)
1 diff
(99.8 %id)
AI701908 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .o-u 670 to 1121 452 to 1 exact tiling clone,   452/456
(99 %)
0 diff
(100 %id)
AI032500 liver and spleen .o-u 708 to 1118 411 to 1 exact     411/411
(100 %)
0 diff
(100 %id)
R01262 liver and spleen .o-u 712 to 1111 410 to 1       410/414
(99 %)
10 diff
(97.6 %id)
AA176987   .o-u 781 to 1127 347 to 2 exact tiling clone,   346/367
(94 %)
0 diff
(100 %id)
N74068 liver and spleen .o-u 908 to 1118 212 to 1   to resequence,   212/217
(97 %)
1 diff
(99.6 %id)
AA573006 liposarcoma .o-u 909 to 1118 1 to 210   AAA Possibly primed on the genome, locally A rich (27/30 A in genome downstream of last aligned base) 210/210
(100 %)
2 diff
(99.1 %id)
AW977092   .p-u 1 to 592 594 to 1 exact tiling clone, Submitted on the opposite strand 594/594
(100 %)
8 diff
(98.7 %id)
AW271954 Kidney .p-u 121 to 594 477 to 4       474/477
(99 %)
0 diff
(100 %id)
AA737336 germinal center B cell .p-u 180 to 594 423 to 9   tiling clone,   415/423
(98 %)
0 diff
(100 %id)
AI888938 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .p-u 183 to 593 411 to 1       411/411
(100 %)
0 diff
(100 %id)
AA764899 germinal center B cell .p-u 192 to 594 411 to 9       403/411
(98 %)
0 diff
(100 %id)
DA909677   .q 1 to 577 2 to 578 L94F tiling clone, capped   577/577
(100 %)
1 diff
(99.9 %id)
DB214029 trachea .r-u 1 to 554 2 to 556 C18W tiling clone, capped   555/555
(100 %)
2 diff
(99.7 %id)
BG230853 nasopharynx, normal epithelium .r-u 157 to 319 1 to 163 exact tiling clone,   163/163
(100 %)
6 diff
(96.4 %id)
AL712226 human skeletal muscle .s-u 1 to 533 1 to 533 R52G tiling clone,   533/533
(100 %)
2 diff
(99.7 %id)
BF362999 nervous_normal .s-u 77 to 346 281 to 10 L11* tiling clone,   272/328
(82 %)
11 diff
(96.7 %id)
BE164607 head_neck .s-u 90 to 189 121 to 23     Submitted on the opposite strand 99/123
(80 %)
0 diff
(100 %id)
AA320945 adipose tissue, brown Gene RABEP1, variant not shown         Submitted on the opposite strand    
BC041700 Testis, embryonal carcinoma Gene RABEP1, variant not shown       available from MGC, AAA This clone was ignored    
DB298375 cerebellum Gene RABEP1, variant not shown              
DA092256 cerebellum Gene RABEP1, variant not shown       capped      
DA485976 brain Gene RABEP1, variant not shown       capped      
BC065242 Testis, embryonal carcinoma Gene RABEP1, variant not shown       available from MGC, AAA This clone was ignored    
NM_004703.4   Gene RABEP1, variant not shown       RefSeq, AAA This clone was ignored    
NM_001083585.1   Gene RABEP1, variant not shown       RefSeq, AAA This clone was ignored    
BE244131 leukopheresis Gene RABEP1, variant not shown         This clone was ignored    
X77723 endometrium Gene RABEP1, variant not shown         This clone was ignored    
344 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l-u, .m-u, .n, .o-u, .p-u, .q, .r-u, .s-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI